UK Has ‘Much Room For Improvement’ On Genomic Testing Access
Executive Summary
UK patient outcomes would improve under clearer, standardized market access or reimbursement pathways for advanced diagnostic tests, such as those used to screen for cancer, trade groups say.
You may also be interested in...
Diagnostics In Spotlight As UK Launches ‘World-First’ Whole Genome Testing Service
Health care authorities in the UK made several medtech-related announcements this week, one of which is its “groundbreaking” genetic testing service that is set to expedite rare disease diagnosis for babies and children in England.
Exec Chat: Illumina CMO Looks From Pandemic Boom To Future Where Genomics Is ‘Foundational’ To Health Care
Illumina’s chief medical officer Phillip Febbo discusses expanding use cases for gene sequencing, the firm’s planned introduction of new long-read sequencing technology Infinity, the status of its Grail acquisition, and additional plans for 2022.
Interview: Diagnostics' Vital Role Is Something to Shout About, Says UK's BIVDA
Diagnosing and mapping COVID-19 are the keys to controlling the pandemic, and the IVDs industry is crucial to their success. But unclear messaging from the center is not helping, says incoming BIVDA chief operating officer Helen Dent.